Home β€Ί Stock analysis β€Ί CURX

Curanex Pharmaceuticals (CURX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

CURX slides 4.3% to $4.62. Closed at $4.62, -4.35% vs the prior close of $4.83. Day range $4.61–$4.95, opened at $4.85.

Last close$4.62-4.35%
Day range4.61–4.95
Open4.85
Volume10.32K
52-week range3.58–16.94
Avg volume (20d)22.90K

CURX daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” CURX slides 4.3% to $4.62
Oct 15, 2026 β€” CURX dips 2.6% to $4.83
Oct 14, 2026 β€” CURX rises 1.6% to $4.96
Oct 13, 2026 β€” CURX ends flat (+0.0%) to $4.88
Oct 12, 2026 β€” CURX slides 8.1% to $4.88
Oct 9, 2026 β€” CURX jumps 11.6% to $5.31, a 1-month high
Oct 8, 2026 β€” CURX ends flat (-0.2%) to $4.76
Oct 7, 2026 β€” CURX slides 4.4% to $4.77 on 4.6x normal volume
Oct 6, 2026 β€” CURX rises 0.6% to $4.99 on 2.0x normal volume
Oct 5, 2026 β€” CURX jumps 5.1% to $4.96 on 4.4x normal volume
Oct 2, 2026 β€” CURX slides 5.0% to $4.72

CURX latest news & SEC filings

Every SEC filing by or about CURX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 4, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-041546

Aug 17, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-038764

Aug 14, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001493152-26-038145

Jul 21, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001493152-26-034091

Jun 29, 2026 Β· Form DEF 14C β€” DEF 14C filing

DEF 14C filing

Source: SEC EDGAR filing 0001493152-26-030447

Things to know before you trade CURX

CURX market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20264.854.954.614.6210.32K
Oct 15, 20264.875.194.754.8316.00K
Oct 14, 20264.405.004.314.969.10K
Oct 13, 20264.884.884.884.880
Oct 12, 20265.045.174.884.887.90K
Oct 9, 20264.615.314.615.3115.70K
Oct 8, 20264.754.904.514.7614.40K
Oct 7, 20264.795.154.454.77102.00K
Oct 6, 20265.095.294.884.9942.30K
Oct 5, 20264.325.044.324.9687.40K
Oct 2, 20264.705.104.594.722.70K
Oct 1, 20264.935.054.754.978.00K
Sep 30, 20264.995.034.995.031.20K
Sep 29, 20265.085.084.974.971.00K
Sep 28, 20264.815.274.445.0320.50K
Sep 25, 20264.415.004.404.7471.30K
Sep 24, 20264.454.504.304.453.40K
Sep 23, 20264.444.474.404.474.30K
Sep 22, 20264.804.884.404.5824.10K
Sep 21, 20264.294.504.054.3716.40K

About Curanex Pharmaceuticals

Curanex Pharmaceuticals (CURX) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in JERICHO, NY. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 2025942.

CURX board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

CURX financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-4.23M-0.17$-10.48M
Dec 31, 2024β€”$-361.51K-0.03$-555.58K

Latest balance sheet: total assets $5.07M, total liabilities $286.25K, cash $2.94M (as of Jun 30, 2026).

CURX earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on CURX

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.